Inpatient Versus Outpatient Administration of Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia

被引:0
作者
Sanka, Pranavi [1 ]
Egan, Pamela [2 ]
Niroula, Rabin [2 ]
Yakirevich, Inna [3 ]
Gardner, David [3 ]
Reagan, John L. [4 ]
机构
[1] Brown Univ, Lifespan, Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Lifespan Canc Inst, Legoretta Canc Ctr, Providence, RI 02912 USA
[3] Lifespan Canc Inst, Providence, RI USA
[4] Brown Univ, Legorreta Canc Ctr, Providence, RI 02912 USA
关键词
D O I
10.1182/blood-2023-184948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
    Morsia, Erika
    McCullough, Kristen
    Joshi, Maansi
    Cook, Joselle
    Alkhateeb, Hassan B.
    Al-Kali, Aref
    Begna, Kebede
    Elliott, Michelle
    Hogan, William
    Litzow, Mark
    Shah, Mithun
    Pardanani, Animesh
    Patnaik, Mrinal
    Tefferi, Ayalew
    Gangat, Naseema
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1511 - 1521
  • [22] Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents
    Johnson, Isla M.
    Bezerra, Evandro D.
    Farrukh, Faiqa
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2021, 138
  • [23] Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
    Johnson, Isla M.
    Bezerra, Evandro D.
    Farrukh, Faiqa
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun Vinod
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD ADVANCES, 2022, 6 (17) : 5227 - 5231
  • [24] Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
    Jin, Dian
    He, Jingsong
    Chen, Haoguang
    Wu, Wenjun
    Han, Xiaoyan
    Le, Jing
    Shu, Wenxiu
    Yang, Qianqian
    Pei, Shanshan
    Cai, Zhen
    He, Donghua
    CANCER MEDICINE, 2024, 13 (14):
  • [25] An Outpatient Management for First Cycle of Venetoclax and Hypomethylating Agents Results in Reduced Infection Rate and Hospitalizations in Acute Myeloid Leukemia Patients
    Nanni, Jacopo
    Papayannidis, Cristina
    Cristiano, Gianluca
    Marconi, Giovanni
    Sartor, Chiara
    Parisi, Sarah
    Saed, Rashed
    Zannoni, Letizia
    Ottaviani, Emanuela
    Bandini, Lorenza
    Testoni, Nicoletta
    Baldazzi, Carmen
    Ricci, Paolo
    Bezzi, Chiara Di Giovanni
    Abdalatif, Rania
    Paolini, Stefania
    Cavo, Michele
    Curti, Antonio
    BLOOD, 2021, 138
  • [26] Hypomethylating Agent/Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia
    Jamy, Omer Hassan
    Worth, Sarah
    Rangaraju, Sravanti
    Bachiashvili, Kimo
    Vachhani, Pankit
    Bhatia, Ravi
    BLOOD, 2021, 138
  • [27] Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax
    Cordella, Stefano
    Giusti, Davide
    De Bellis, Eleonora
    Dargenio, Michelina
    Creti, Federica
    Lazzarotto, Davide
    Cattaneo, Chiara
    Fracchiolla, Nicola Stefano
    Piccini, Matteo
    Forghieri, Fabio
    Pagano, Livio
    Candoni, Anna
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (05)
  • [28] Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents
    Kayser, Sabine
    Sanber, Khaled
    Marconi, Giovanni
    Mattei, Agnese
    Luskin, Marlise R.
    Kelkar, Amar
    Cerrano, Marco
    Kristensen, Daniel Tuyet
    Roug, Anne Stidsholt
    Sartor, Chiara
    Giglio, Fabio
    Riva, Marta
    Rizzo, Lorenzo
    Saraceni, Francesco
    Guerzoni, Selene
    Lessi, Federica
    Borlenghi, Erika
    Levis, Mark J.
    Schlenk, Richard F.
    Jain, Tania
    Papayannidis, Cristina
    HAEMATOLOGICA, 2025, 110 (02) : 378 - 384
  • [29] Venetoclax in Combination with Hypomethylating Agents Compared to Standard Chemotherapy in Relapsed/ Refractory Acute Myeloid Leukemia
    Mohassel, Leila
    Yakubi, Hanna
    Jones, Kendra
    Wang, Hongkun
    Shafer, Danielle
    BLOOD, 2022, 140 : 6158 - 6159
  • [30] Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents
    Zainaldin, Carl
    Arora, Sankalp
    Bathini, Srilakshmi
    Gupta, Udita
    Pandya, Vishruti
    Bae, Sejong
    Worth, Sarah
    Bachiashvili, Kimo
    Bhatia, Ravi
    Godby, Kelly
    Jamy, Omer
    Rangaraju, Sravanti
    Diamond, Barry
    Oliver, Josh D.
    Salzman, Donna
    Di Stasi, Antonio
    Vachhani, Pankit
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3245 - 3248